Importantly, another Kaplan–Meier analysis revealed that the signature that combines low-level IMPA2 and autophagy gene set predicted a poor overall survival rate in TCGA ccRCC patients (Figure 6D). The gene discussed is IMPA2; the disease is nonpapillary renal cell carcinoma.